See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers have unveiled a breakthrough showing that a subset of ...
GSK plc GSK on Monday reported interim results from its registrational Phase 2 AZUR-1 trial of Jemperli (dostarlimab) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results